EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of testosterone-to-estradiol ratio with inflammation and clinical outcomes among postmenopausal HFpEF

Miaomiao Qi iD, Qiongying Wang, Runmin Sun, Mingze Li, Lulu Zhu, Wenting Wang, Xin Fan, Jing Yu iD

Endocrine Connections · 01.08.2026 · 15 (8)

DOI: 10.1530/ec-26-0231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine Connections, online erschienen am 24.07.2026. Verfasst von Miaomiao Qi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Lanzhou University Second Hospital , Lanzhou, China. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Graphical Abstract Abstract Objective Sex hormones are linked to the inflammation and diastolic dysfunction. The testosterone-to-estradiol ratio (T/E2) may capture the relative androgenic-to-estrogenic balance more comprehensively. We investigated whether T/E2 is associated with systemic inflammation, diastolic dysfunction, and short-term outcomes in postmenopausal women with HFpEF.

Methods

This single-center prospective cohort included 184 postmenopausal women with HFpEF who were followed up for 12 months. Sex hormones were measured using chemiluminescent immunoassays. Associations of T/E2 with inflammatory biomarkers, echocardiographic indices, 12-month NT-proBNP, and clinical outcomes were evaluated using correlation, multivariable linear regression, and logistic regression analyses.

Results

Median testosterone and estradiol concentrations were 14.61 ng/dL and 18.60 pg/mL, respectively. Higher T/E2 was independently associated with lower hs-CRP (β = −0.353, P < 0.001), NLR (β = −0.162, P = 0.015), IL-6 (β = −0.166, P = 0.005), and E/e′ (β = −0.073, P = 0.032), but not with D-dimer (β =−0.339, P = 0.433), LAD (β = −0.073, P = 0.032), or 12-month NT-proBNP (β = 0.065, 95% CI: −0.115 to 0.245; P = 0.481). The 12-month composite clinical endpoint occurred in 54 participants (29.3%). Higher T/E2 was associated with lower odds of the composite endpoint (OR = 0.653, 95% CI: 0.450–0.949; P = 0.025), mainly reflecting heart failure hospitalization (OR = 0.618, 95% CI: 0.417–0.915; P = 0.016).

Conclusion

In postmenopausal women with HFpEF, lower T/E2 is associated with greater systemic inflammation, worse diastolic hemodynamics, and higher odds of short-term clinical events. These findings suggest that T/E2 may serve as a candidate endocrine-inflammatory marker for HFpEF phenotyping in postmenopausal women.

Schlagwörter

Stichwörter der Autor:innen

heart failure with preserved ejection fractioninflammationmenopausetestosterone-to-estradiol ratio

Autor:innen und Institutionen

  • Department of Cardiology, Lanzhou University Second Hospital , Lanzhou, China.
  • Second Clinical School, Lanzhou University , Lanzhou, China.

ORCID-Profile: Miaomiao Qi, Jing Yu

Zitieren

APA

Qi, M., Wang, Q., Sun, R., Li, M., Zhu, L., Wang, W., Fan, X., & Yu, J. (2026). Association of testosterone-to-estradiol ratio with inflammation and clinical outcomes among postmenopausal HFpEF. Endocrine Connections, 15(8). https://doi.org/10.1530/ec-26-0231

Vancouver

Qi M, Wang Q, Sun R, Li M, Zhu L, Wang W, et al. Association of testosterone-to-estradiol ratio with inflammation and clinical outcomes among postmenopausal HFpEF. Endocrine Connections. 2026;15(8). doi:10.1530/ec-26-0231

BibTeX
@article{Qi2026,
  author = {Qi, Miaomiao and Wang, Qiongying and Sun, Runmin and Li, Mingze and Zhu, Lulu and Wang, Wenting and Fan, Xin and Yu, Jing},
  title = {Association of testosterone-to-estradiol ratio with inflammation and clinical outcomes among postmenopausal HFpEF},
  journal = {Endocrine Connections},
  year = {2026},
  volume = {15},
  number = {8},
  doi = {10.1530/ec-26-0231}
}
Kostenlos starten →